Literature DB >> 12083439

Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control.

M W Tyndall1, D Patrick, P Spittal, K Li, M V O'Shaughnessy, M T Schechter.   

Abstract

Injection drug use is inextricably linked to commercial sex work and the transmission of sexually transmitted disease (STD). In many communities prevention efforts have been stalled owing to the marginal existence of this community. This study describes the sexual activities, condom use, reported STDs, and commercial sex work in a large cohort of injection drug users. Seventy two per cent of male and 92% of female subjects in the cohort were sexually active. Among female subjects, 57% reported more than 100 lifetime partners. Condoms were generally not used with regular partners, used about half the time with casual partners, and used about 80% of the time with paying partners. Female sex workers were more likely to have unstable housing and to report incarceration in the previous six months. Reducing the transmission of STDs and HIV in drug using communities is a public health priority. While existing prevention programmes should be strengthened, innovative approaches to STD surveillance, diagnosis, and prevention are needed.

Entities:  

Mesh:

Year:  2002        PMID: 12083439      PMCID: PMC1765822          DOI: 10.1136/sti.78.suppl_1.i170

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  43 in total

1.  Gender differences in the rates and correlates of HIV risk behaviors among drug abusers.

Authors:  Audrey Brooks; Christina S Meade; Jennifer Sharpe Potter; Yuliya Lokhnygina; Donald A Calsyn; Shelly F Greenfield
Journal:  Subst Use Misuse       Date:  2010-06-10       Impact factor: 2.164

2.  The cost-effectiveness of a modestly effective HIV vaccine in the United States.

Authors:  Elisa F Long; Douglas K Owens
Journal:  Vaccine       Date:  2011-04-19       Impact factor: 3.641

Review 3.  The dynamics of substance use and sex networks in HIV transmission.

Authors:  Maureen Miller
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

4.  Dissolution of primary intimate relationships during incarceration and implications for post-release HIV transmission.

Authors:  Maria R Khan; Lindy Behrend; Adaora A Adimora; Sharon S Weir; Becky L White; David A Wohl
Journal:  J Urban Health       Date:  2011-04       Impact factor: 3.671

5.  Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors.

Authors:  Elisa Lloyd-Smith; Evan Wood; Kathy Li; Julio S G Montaner; Thomas Kerr
Journal:  Drug Alcohol Depend       Date:  2008-09-20       Impact factor: 4.492

6.  Differential risk factors for HIV drug and sex risk-taking among non-treatment-seeking hospitalized injection drug users.

Authors:  Denise Crooks; Judith Tsui; Bradley Anderson; Shernaz Dossabhoy; Debra Herman; Jane M Liebschutz; Michael D Stein
Journal:  AIDS Behav       Date:  2015-03

7.  Unsafe sex among HIV positive individuals: cross-sectional and prospective predictors.

Authors:  Thom Reilly; Susan I Woodruff; Laurie Smith; John D Clapp; Jerry Cade
Journal:  J Community Health       Date:  2010-04

8.  Sexual HIV risk behaviors in a treatment-refractory opioid-dependent sample.

Authors:  R Kathryn McHugh; Meara Weitzman; Steven A Safren; Heather W Murray; Mark H Pollack; Michael W Otto
Journal:  J Psychoactive Drugs       Date:  2012 Jul-Aug

9.  Sexual HIV/HSV-2 risk among drug users in New York City: an HIV testing and counseling intervention.

Authors:  Marlene Pantin; Noelle R Leonard; Holly Hagan
Journal:  Subst Use Misuse       Date:  2013-03-25       Impact factor: 2.164

10.  The prevalence and incidence of sexually transmitted infections in a prospective cohort of injection drug users in Vancouver, British Columbia.

Authors:  Laura M Kuyper; Courtney Lc Collins; Thomas Kerr; Robert S Hogg; Kathy Li; Mark W Tyndall; Julio Sg Montaner; Evan Wood
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-07       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.